0
Invited Critique |

Will Adjuvant Antiviral Therapy Close the Outcome Gap Between Liver Transplantation and Resectional Therapy for Hepatitis B Virus–Associated Hepatocellular Cancer?: The Answer Is in Reach:  Comment on “Impact of Antiviral Therapy on the Survival of Patients After Major Hepatectomy for Hepatitis B Virus–Related Hepatocellular Carcinoma”

Christopher Wolfgang, MD, PhD
Arch Surg. 2011;146(6):682. doi:10.1001/archsurg.2011.113.
Text Size: A A A
Published online

Extract

The biology of hepatocellular carcinoma (HCC) is unique compared with other gastrointestinal tract cancers because most cases are caused by viral agents. It would follow that modulation of factors related to the infection has the potential to alter the natural history of HCC tumorigenesis. Indeed, the use of antiviral therapy in patients with chronic hepatitis B virus (HBV) infection in endemic populations of Asia has been shown to significantly reduce the risk of HCC.1 Despite this well-documented benefit, very little is known about the efficacy of antiviral therapy after a potentially curative resection of HBV-associated HCC. A recent meta-analysis2 identified only 2 studies on this subject and reported a favorable effect on survival, but not recurrence, with adjuvant therapy including antiviral treatments.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Cancer, Family History

The Rational Clinical Examination
Original Article: Does This Patient Have a Family History of Cancer?

brightcove.createExperiences();